LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced today that it has commenced preliminary due diligence and strategic planning for expansion into Colombia. The company stated that the initial phase includes evaluating corporate, regulatory, legal, operational, and commercial requirements for establishing a Colombian operating subsidiary and deploying its digital healthcare platform in the market.
Management believes Colombia represents an attractive long-term market as part of its broader Latin American expansion strategy. The ongoing review process is expected to include assessments of corporate formation, regulatory compliance, healthcare technology implementation, strategic partnerships, and local operational infrastructure. The company noted that the evaluation aims to build upon its growing healthcare ecosystem by identifying opportunities to expand access to telehealth infrastructure, healthcare coordination technologies, digital healthcare services, and artificial intelligence-driven healthcare solutions in additional Latin American markets.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: "Colombia represents an important strategic opportunity as we continue executing our long-term vision of building an integrated digital healthcare ecosystem across Latin America. While we remain in the early stages of evaluating market entry requirements, we believe it is important to establish the proper legal, operational, and strategic foundation before expanding into new jurisdictions."
The company emphasized that the expansion initiative remains in the preliminary planning stage. Management intends to complete the required corporate, regulatory, and operational review before proceeding with the establishment of a Colombian subsidiary and expects to provide updates as material developments occur. This move aligns with the company's focus on improving healthcare accessibility in underserved and developing markets across Latin America. For more information, visit https://latamed.ai or review the company's SEC filings at www.sec.gov.
